Sangqi tea (SQT), a 1-1 combination of Mori Folium (MF) and Astragali Radix (AR), has been used as a functional tea for metabolic health. In this study, the effects of SQT on glucose homeostasis were evaluated using a Caenorhabditis elegans model, integrating network pharmacology, bioinformatics, transcriptomics, molecular docking, and molecular dynamics to identify candidate compounds and investigate potential glucose-regulatory mechanisms. In high-glucose-fed worms, SQT significantly reduced glucose and triglyceride levels and lipid accumulation while alleviating oxidative stress. Integrated network pharmacology, transcriptomic, and genetic analyses supported the involvement of insulin/IGF-1 signaling (IIS) and SKN-1/Nrf2-associated signaling in the metabolic effects of SQT, with increased nuclear localization of DAF-16 and SKN-1 and altered expression of their downstream effector genes. The integrated strategy used in this study may also provide a useful reference for investigating other combined formulations whose individual components have been extensively studied but whose integrated effects and underlying mechanisms remain unclear.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: